We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Namyong Kim, PhD

Namyong Kim, PhD profile page


 at Curiox Biosystems

Namyong Kim brings with him more than 15 years of experiences in scientific research and technical management in the development of biotech instrumentation. He received his Ph.D. in Chemistry from the Massachusetts Institute of Technology (MIT), and his B.Sc. from the Korea Advanced Institute of Science and Technology (KAIST). He holds more than 10 patents and patent applications, and has published in a number of scientific publications in peer-reviewed journals. DropArray™ technology was developed by a research group led by Dr. Namyong Kim at the Institute of Bioengineering and Nanotechnology (IBN). The group subsequently spun out of the IBN in 2008 and formed Curiox Biosystems, backed primarily by Nanostart AG, a renowned venture capital firm in Germany; and Exploit Technologies, the commercializing arm of A*STAR. The investment of various private equity firms led to Curiox's technology and global footprint expanding, with Laminar Wash™ technology at the forefront. Curiox Biosystems was listed in the Korean Stock Market on August 3, 2023, marking the start of the new era for the company and its technologies that will impact the standards of cell sample prep globally.

Got a Question for Namyong Kim, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly